Cover Image

Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation

Saved in:

Bibliographic Details
Main Authors:	Rodrigo A. Gutierrez, BS (Author), Payton Smith, BS (Author), Allison Kranyak, MD (Author), Mitchell Davis, MD (Author), John Koo, MD (Author)
Format:	Book
Published:	Elsevier, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy Of Pimozide In Delusion Of Parasitosis
by: Chakraborty Kalyan, et al.
Published: (1998)

Tardive dyskinesia
by: Violetta A. Tolmacheva
Published: (2021)

Health providers induced iatrogenic delusions of infestation
by: Shah PR, et al.
Published: (2019)

Pathophysiology, prognosis and treatment of tardive dyskinesia
by: Hiroyoshi Takeuchi, et al.
Published: (2022)

New and emerging treatments for symptomatic tardive dyskinesia
by: Rana AQ, et al.
Published: (2013)

Treatment-induced Delusions of Infestation Associated with Increased Brain Dopamine Levels
by: Emilie Fowler, et al.
Published: (2018)

Tardive dyskinesia: understanding current challenges in diagnosis and treatment
by: David Taylor, et al.
Published: (2023)

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
by: Robert H. Farber, et al.
Published: (2024)

Improvement of Tardive Dyskinesia during Mindfulness Meditation
by: Maria Angela Santoro, et al.
Published: (2021)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021)

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
by: Rikinkumar S. Patel, et al.
Published: (2019)

Tardive Dyskinesia, Oral Parafunction, and Implant-Supported Rehabilitation
by: S. Lumetti, et al.
Published: (2016)

Management of delusions of parasitosis: an interview with experts in psychodermatology
by: Nicholas Brownstone, MD, et al.
Published: (2022)

Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
by: Claassen Daniel O. MD, et al.
Published: (2023)

A Study on Drug-Induced Tardive Dyskinesia: Orofacial Musculature Involvement and Patient's Awareness
by: Arunachalam M Anusa, et al.
Published: (2018)

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin
by: Lourdes Aguilar, et al.
Published: (2019)

Delusions of parasitosis
by: Jillian W Wong, et al.
Published: (2013)

Restless tongue: Lingual Tardive Dyskinesia - A rare case report
by: Pritesh Ruparelia, et al.
Published: (2022)

Digital functionally generated path technique in a tardive dyskinesia patient
by: A/Prof Du Hyeong Lee, et al.
Published: (2023)

Association Study of the Complement Component C4 Gene in Tardive Dyskinesia
by: Clement C. Zai, et al.
Published: (2019)

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia
by: Kumsa A, et al.
Published: (2020)

Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States
by: Rakesh Jain, et al.
Published: (2023)

Physical Function-Tardive Dyskinesia (PATD) on Critical Patients in Intensive Care Unit
by: Heru Suwardianto, et al.
Published: (2017)

Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders
by: Chang FC, et al.
Published: (2014)

Investigation of the HSPG2 Gene in Tardive Dyskinesia - New Data and Meta-Analysis
by: Clement C. Zai, et al.
Published: (2018)

Correction: Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States
by: Rakesh Jain, et al.
Published: (2024)

Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies
by: Evangelia Eirini Tsermpini, et al.
Published: (2022)

Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington’s Disease and Tardive Dyskinesia
by: Frank S, et al.
Published: (2023)

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations
by: Jungjin Kim, et al.
Published: (2014)

Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan
by: Yasuhiro Mori, et al.
Published: (2022)

Altered DNA methylation of CYP2E1 gene in schizophrenia patients with tardive dyskinesia
by: Ping Zhang, et al.
Published: (2022)

Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
by: Solmi M, et al.
Published: (2018)

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report
by: Shintaro Sakai, et al.
Published: (2021)

Pimozide cf. Haloperidol in Tourette Syndrome
by: J Gordon Millichap
Published: (1997)

Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review
by: Meyer Jonathan M. MD, et al.
Published: (2023)

(+)-9-Trifluoroethoxy-α-Dihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia
by: Wenyan Wang, et al.
Published: (2021)

A descriptive analysis of spontaneous reports of antipsychotic‐induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database
by: Yosuke Saga, et al.
Published: (2024)

Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study
by: Caroline M. Tanner, et al.
Published: (2023)

Pustular rosacea secondary to Demodex infestation shown with reflectance confocal microscopy
by: Joel Cohen, BS, et al.
Published: (2023)

Delusions in Context
Published: (2018)